The Technology and Life Sciences team guided Tropic on the close of its oversubscribed $105 million Series C financing to accelerate the global commercial scale-up of its banana and rice portfolios and advance its pipeline of climate-resilient crops. The round reflects surging global demand for resilient, sustainable food solutions and Tropic's proven ability to rapidly and efficiently bring high-performance gene‑edited crops to market. The financing follows a milestone year in which Tropic launched the first new commercial banana varieties in more than 75 years.
Tropic is a pioneering tropical seeds company dedicated to the development of healthier, more robust, high-performing varieties of tropical crops. The company's current core crop portfolio focusses on banana and rice, which together provide a source of livelihood to billions of people worldwide. Tropic utilises its proprietary GEiGS® platform and other cutting-edge gene-editing technologies to develop improved crops with increased disease resistance, higher yields, and environmentally sustainable traits. By harnessing the power of advanced genetic engineering, Tropic is committed to addressing global agricultural challenges and providing innovative solutions that benefit farmers, consumers, and the environment.
The Goodwin team was led by Elizabeth Rhodes, George Fagan, Emily Townsend, and Oliver Watt.
For more information on the deal, please read the press release.